Login / Signup

Targeting the SREBP-1/Hsa-Mir-497/SCAP/FASN Oncometabolic Axis Inhibits the Cancer Stem-like and Chemoresistant Phenotype of Non-Small Cell Lung Carcinoma Cells.

Tung-Yu TiongPei-Wei WengChun-Hua WangSyahru Agung SetiawanVijesh Kumar YadavNarpati Wesa PikatanIat-Hang FongChi-Tai YehChia-Hung HsuKuang-Tai Kuo
Published in: International journal of molecular sciences (2022)
Targeting the SREBP-1/hsa-miR-497 signaling axis is a potentially effective anticancer therapeutic strategy for NSCLC.
Keyphrases
  • cell proliferation
  • long non coding rna
  • long noncoding rna
  • cancer therapy
  • papillary thyroid
  • single cell
  • cell therapy
  • stem cells
  • squamous cell carcinoma
  • bone marrow
  • lymph node metastasis
  • tyrosine kinase